S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
What Is WallStreetBets and What Stocks Are They Targeting?
Most profitable less than $5 stock in the world? (Ad)pixel
Closing prices for crude oil, gold and other commodities
Pipeline break spills 45,000 gallons of diesel in Wyoming
2 Important Retail Stock Battles to Watch
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
Wall Street builds on gains, heads for 4-week winning streak
Judge revives Obama-era ban on coal sales from federal lands
In Biden's big bill: Climate, health care, deficit reduction
Shocking Transcript: Financial Chaos Now Brace yourself for what's coming next (Ad)
NASDAQ:PRVB

Provention Bio - PRVB Earnings Date, Estimates & Call Transcripts

$5.62
+0.34 (+6.44%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$5.33
$5.76
50-Day Range
$3.43
$5.62
52-Week Range
$3.18
$8.04
Volume
966,280 shs
Average Volume
631,934 shs
Market Capitalization
$359.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.33

Earnings Summary

Upcoming
Earnings Date
Nov. 3Estimated
Actual EPS
(Aug. 4)
-$0.46 Beat By $0.03
Consensus EPS
(Aug. 4)
-$0.49
Last Year's Q3 EPS
(8/5/2021)
-$0.46
Skip Charts & View Estimated and Actual Earnings Data

PRVB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PRVB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Provention Bio Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20221($0.40)($0.40)($0.40)
Q4 20221($0.37)($0.37)($0.37)

PRVB Earnings Date and Information

Provention Bio last posted its earnings data on August 4th, 2022. The reported ($0.46) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.49) by $0.03. The business earned $0.75 million during the quarter, compared to analysts' expectations of $0.80 million. Provention Bio has generated ($1.65) earnings per share over the last year (($1.65) diluted earnings per share). Earnings for Provention Bio are expected to grow in the coming year, from ($1.83) to ($1.38) per share. Provention Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based off prior year's report dates.

Provention Bio Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/3/2022
(Estimated)
        
8/4/2022Q2 2022($0.49)($0.46)+$0.03($0.46)$0.80 million$0.75 million    
5/5/2022Q1 2022($0.45)($0.35)+$0.10($0.35)$0.73 million$0.58 million
2/24/2022Q4 2021($0.44)($0.41)+$0.03($0.41)$0.71 million$0.72 million    
11/4/20219/30/2021($0.51)($0.43)+$0.08($0.43)$3.75 million$0.68 million    
8/5/20216/30/2021($0.51)($0.46)+$0.05($0.46)  
5/6/20213/31/2021($0.48)($0.52)($0.04)($0.52)  
2/24/202112/31/2020($0.50)($0.58)($0.08)($0.58)  
11/5/20209/30/2020($0.40)($0.56)($0.16)($0.56)  
8/6/20206/30/2020($0.28)($0.45)($0.17)($0.45)  
5/7/20203/31/2020($0.25)($0.26)($0.01)($0.26)  
3/12/202012/31/2019($0.24)($0.22)+$0.02($0.22)  
11/5/2019Q3($0.30)($0.24)+$0.06($0.24)  
8/6/2019Q2 2019($0.3050)($0.32)($0.0150)($0.32)
5/8/2019Q1($0.1850)($0.29)($0.1050)($0.29)
3/19/201912/31/2018($0.19)($0.15)+$0.04($0.15)  
11/8/2018Q3($0.17)($0.17)($0.17)
8/13/2018Q2 2018($1.05)($1.05)($1.05)












Provention Bio Earnings - Frequently Asked Questions

When is Provention Bio's earnings date?

Provention Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based off last year's report dates. Learn more on PRVB's earnings history.

Did Provention Bio beat their earnings estimates last quarter?

In the previous quarter, Provention Bio (NASDAQ:PRVB) reported ($0.46) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.49) by $0.03. Learn more on analysts' earnings estimate vs. PRVB's actual earnings.

How can I listen to Provention Bio's earnings conference call?

The conference call for Provention Bio's latest earnings report can be listened to online. Listen to Conference Call

How can I read Provention Bio's conference call transcript?

The conference call transcript for Provention Bio's latest earnings report can be read online. Read Transcript

How much revenue does Provention Bio generate each year?

Provention Bio (NASDAQ:PRVB) has a recorded annual revenue of $1.39 million.

How much profit does Provention Bio generate each year?

Provention Bio (NASDAQ:PRVB) has a recorded net income of -$114.43 million. PRVB has generated -$1.65 earnings per share over the last four quarters.

What is Provention Bio's EPS forecast for next year?

Provention Bio's earnings are expected to grow from ($1.83) per share to ($1.38) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:PRVB) was last updated on 8/13/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.